Earnings History Data for Protalix BioTherapeutics, Inc. (PLX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | PLX | Protalix BioTherapeutics, Inc. | 97.08 | 0.03 | 0.06 | -0.04 | Protalix BioTherapeutics GAAP EPS of $0.03, revenue of $17.96M [11/14/2024 6:51 AM] |
1.40 | 0.16 (12.98%) |
1.26 | 0.02 (1.61%) |
0.82 - 1.90 | 1,376,242 | 320,000 | 56,174 | ||
| 14-08-2024 | PM | PLX | Protalix BioTherapeutics, Inc. | 76.25 | -0.03 | 0.02 | 0.21 | Protalix BioTherapeutics GAAP EPS of -$0.03 misses by $0.05, revenue of $13.47M beats by $0.97M [8/14/2024 6:52 AM] |
0.9301 | -0.11 (-10.57%) |
1.00 | -0.04 (-3.85%) |
0.82 - 2.09 | 601,460 | 170,000 | 13,689 | ||
| 10-05-2024 | PM | PLX | Protalix BioTherapeutics, Inc. | 83.28 | -0.06 | 0.00 | -0.05 | Protalix BioTherapeutics GAAP EPS of -$0.06 misses by $0.04, revenue of $3.75M [5/10/2024 6:54 AM] |
1.11 | -0.14 (-11.20%) |
1.04 | -0.21 (-16.80%) |
1.03 - 3.10 | 1,653,271 | 520,000 | 474,817 | ||
| 14-03-2024 | PM | PLX | Protalix BioTherapeutics, Inc. | 104.32 | -0.07 | -0.03 | -0.07 | Protalix BioTherapeutics GAAP EPS of $0.09 misses by $0.01, revenue of $65.49M beats by $1.54M [3/14/2024 6:51 AM] |
1.36 | -0.16 (-10.20%) |
1.54 | 0.02 (1.30%) |
1.21 - 3.55 | 1,167,881 | 360,000 | 34,548 | ||
| 06-11-2023 | PM | PLX | Protalix BioTherapeutics, Inc. | 120.97 | -0.04 | -0.07 | -0.07 | Protalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71M [11/6/2023 6:53 AM] |
1.52 | -0.33 (-17.83%) |
1.71 | -0.14 (-7.57%) |
1.00 - 3.55 | 1,445,604 | 420,000 | 222,418 | ||
| 07-08-2023 | PM | PLX | Protalix BioTherapeutics, Inc. | 112.51 | 0.21 | -0.04 | -0.11 | Protalix BioTherapeutics beats Q2 top and bottom line estimates [8/7/2023 6:54 AM] |
1.88 | 0.22 (12.95%) |
1.93 | 0.27 (16.27%) |
1.00 - 3.55 | 3,446,343 | 750,000 | 1,630,204 | ||
| 04-05-2023 | PM | 6:50 AM ET (May 4) |
PLX | Protalix BioTherapeutics, Inc. | 151.49 | -0.05 | 0.00 | -0.05 | Protalix BioTherapeutics GAAP EPS of -$0.05, revenue of $9.59M [5/4/2023 6:53 AM] |
3.33 | 0.18 (5.72%) |
3.02 | -0.13 (-4.13%) |
0.98 - 3.36 | 3,207,987 | 2,300,000 | 188,740 | |
| 27-02-2023 | PM | 6:50 AM ET (Feb 27) |
PLX | Protalix BioTherapeutics, Inc. | 83.60 | -0.07 | -0.15 | -0.14 | Protalix BioTherapeutics GAAP EPS of -$0.22 beats by $0.17, revenue of $62.89M beats by $17.75M [2/27/2023 6:37 AM] |
1.90 | 0.08 (4.40%) |
1.80 | -0.02 (-1.10%) |
0.80 - 2.02 | 2,072,542 | 940,000 | 320,169 | |
| 14-11-2022 | PM | 6:50 AM ET (Nov 14) |
PLX | Protalix BioTherapeutics, Inc. | 51.25 | -0.07 | -0.15 | -0.09 | Protalix BioTherapeutics GAAP EPS of -$0.07, revenue of $14.18M [11/14/2022 6:54 AM] |
1.05 | 0.0 (0.00%) |
1.14 | 0.09 (8.57%) |
0.70 - 2.00 | 135,321 | 80,000 | 32,656 | |
|
||||||||||||||||||
| 15-08-2022 | PM | 6:50 AM ET (Aug 15) |
PLX | Protalix BioTherapeutics, Inc. | 49.89 | -0.11 | -0.18 | -0.25 | Protalix BioTherapeutics GAAP EPS of -$0.11 beats by $0.07, revenue of $8.75M beats by $6.08M [8/15/2022 6:52 AM] |
1.24 | 0.02 (1.22%) |
1.22 | 0.0 (0.00%) |
0.70 - 2.00 | 88,427 | 190,000 | 22,431 | |
| 16-05-2022 | PM | 6:50 AM ET (May 16) |
PLX | Protalix BioTherapeutics, Inc. | 47.29 | -0.05 | 0.00 | -0.14 | Protalix BioTherapeutics GAAP EPS of -$0.05, revenue of $16.09M [5/16/2022 6:53 AM] |
1.08 | 0.02 (1.90%) |
1.10 | 0.04 (3.77%) |
0.70 - 3.08 | 135,082 | 410,000 | 10,675 | |
| 31-03-2022 | PM | 6:50 AM ET (Mar 31) |
PLX | Protalix BioTherapeutics, Inc. | 48.75 | -0.14 | -0.11 | 0.03 | Protalix BioTherapeutics GAAP EPS of -$0.62 misses by $0.03, revenue of $38.35M beats by $0.76M [3/31/2022 6:52 AM] |
1.07 | 0.02 (1.90%) |
1.06 | 0.01 (0.95%) |
0.70 - 6.64 | 1,064,524 | 330,000 | 17,646 | |
| 15-11-2021 | PM | 6:50 AM ET (Nov 15) |
PLX | Protalix BioTherapeutics, Inc. | 50.11 | -0.09 | -0.12 | -0.14 | 1.16 | 0.02 (1.75%) |
1.14 | 0.0 (0.00%) |
1.07 - 7.02 | 6,266,910 | 580,000 | 40,776 | ||
| 16-08-2021 | PM | 6:50 AM ET (Aug 16) |
PLX | Protalix BioTherapeutics, Inc. | 67.42 | -0.25 | -0.08 | -0.13 | Protalix BioTherapeutics EPS misses by $0.17, beats on revenue [8/16/2021 6:53 AM] |
1.33 | -0.01 (-0.75%) |
1.36 | 0.02 (1.49%) |
1.32 - 7.02 | 665,016 | 630,000 | 21,064 | |
| 14-05-2021 | PM | 6:50 AM ET (May 14) |
PLX | Protalix BioTherapeutics, Inc. | 133.43 | -0.14 | -0.17 | 0.10 | Protalix BioTherapeutics EPS beats by $0.03, beats on revenue [5/14/2021 6:51 AM] |
2.73 | -0.14 (-4.70%) |
2.91 | 0.04 (1.39%) |
2.61 - 7.02 | 1,488,178 | 1,500,000 | 21,625 | |
|
||||||||||||||||||
| 30-03-2021 | PM | 6:50 AM ET (Mar 30) |
PLX | Protalix BioTherapeutics, Inc. | 219.20 | 0.03 | -0.09 | 0.00 | Protalix BioTherapeutics EPS beats by $0.12, beats on revenue [3/30/2021 7:00 AM] |
4.53 | -0.17 (-3.62%) |
4.64 | -0.06 (-1.28%) |
2.12 - 7.02 | 519,439 | 460,000 | 33,603 | |
|
||||||||||||||||||
| 29-10-2020 | PM | 6:50 AM ET (Oct 29) |
PLX | Protalix BioTherapeutics, Inc. | 117.68 | -0.14 | -0.08 | -0.20 | Protalix BioTherapeutics EPS misses by $0.17, beats on revenue [10/29/2020 6:53 AM] |
3.35 | -0.20 (-5.63%) |
3.47 | -0.08 (-2.25%) |
1.85 - 4.86 | 312,418 | 42,422 | 3,049 | |
|
|
||||||||||||||||||
| 10-08-2020 | PM | 6:50 AM ET (Aug 10) |
PLX | Protalix BioTherapeutics, Inc. | 117.44 | -0.13 | -0.20 | -0.50 | Protalix BioTherapeutics EPS beats by $0.07, beats on revenue [8/10/2020 6:52 AM] |
3.57 | -0.02 (-0.56%) |
3.65 | 0.06 (1.67%) |
1.70 - 4.86 | 33,402 | 74,123 | 3,403 | |
|
|
||||||||||||||||||
| 01-06-2020 | PM | 6:50 AM ET (Jun 1) |
PLX | Protalix BioTherapeutics, Inc. | 115.17 | 0.10 | -0.30 | -0.50 | Protalix BioTherapeutics EPS beats by $0.40 [6/1/2020 6:55 AM] |
3.41 | 0.07 (2.10%) |
3.53 | 0.19 (5.69%) |
1.70 - 5.19 | 274,188 | 211,817 | 72,413 | |
|
|
||||||||||||||||||